- 收听数
- 0
- 性别
- 保密
- 听众数
- 44
- 最后登录
- 2023-7-27
- QQ
- UID
- 1081
- 阅读权限
- 30
- 帖子
- 2629
- 精华
- 0
- 在线时间
- 754 小时
- 注册时间
- 2012-11-1
- 科研币
- 23
- 速递币
- -13
- 娱乐币
- 3
- 文献值
- 1
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/12182251 |
|
|